Oral Microto-Nano Genome-Editing System Enabling Targeted Delivery and Conditional Activation of CRISPR-Cas9 for Gene Therapy of Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Oral Microto-Nano Genome-Editing System Enabling Targeted Delivery and Conditional Activation of CRISPR-Cas9 for Gene Therapy of Inflammatory Bowel Disease

Published:2024-08-31 Issue: Volume: Page:
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Lin Sicen¹,Han Shuwen²,Wang Xu¹,Wang Xinyue¹,Shi Xianbao³,He Zhonggui¹⁴^ORCID,Sun Mengchi⁵⁴,Sun Jin¹⁴^ORCID

Affiliation:

1. Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China

2. Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, Huzhou, Zhejiang313000, China

3. Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, China

4. Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang, Liaoning 110016, China

5. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China

Funder

National Key Research and Development Program of China

Liaoning Revitalization Talents Program

Natural Science Foundation of Liaoning Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c07750

Reference45 articles.

1. Inflammatory bowel disease: clinical aspects and established and evolving therapies

2. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

3. Crohn's disease

4. Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease

5. Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships